MEGAN BARNETT: Open Payments
NPI 1538230909 · MC CONNELLSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,394 in 87 payments from 17 companies in 2025. Trend: 2023 $633 · 2024 $1,119 · 2025 $1,394
Food & beverage: $1,394
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $232 |
| PFIZER INC. | 14 | $173 |
| AstraZeneca Pharmaceuticals LP | 9 | $169 |
| ABBVIE INC. | 8 | $161 |
| Lilly USA, LLC | 13 | $143 |
| Sumitomo Pharma America, Inc. | 6 | $137 |
| Otsuka America Pharmaceutical, Inc. | 4 | $67 |
| Exact Sciences Corporation | 2 | $45 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
| Axsome Therapeutics, Inc. | 2 | $34 |
Products named: ELIQUIS, GEMTESA, Wegovy, UBRELVY, FARXIGA, Ozempic, MOUNJARO, JYNARQUE.
Industry payments across PA — which companies pay providers there.
